"There seem to be more cases [of HIV infection] in those who were actually vaccinated," says Keith Gottesdiener, vice president of vaccine and infectious-disease clinical research at Merck, of Whitehouse Station, N.J. "We don't really know the reasons for this."
Insider is glad to hear that the Ebola trials have been stopped!
No comments:
Post a Comment